Stem cell assays in the evaluation of myelotoxicity

por Mangalik, Aroop, Robinson, William A.
Publicado 1981

THE ENHANCING EFFECT OF BONE MARROW CELLS ON THE PRIMARY IMMUNE RESPONSE OF THE ISOLATED PERFUSED SPLEEN

por Atkins, Robert C., Robinson, William A., Eiseman, Ben
Publicado 1970

A Survey of Computational Tools to Analyze and Interpret Whole Exome Sequencing Data

por Hintzsche, Jennifer D., Robinson, William A., Tan, Aik Choon
Publicado 2016

Desmoid Tumors in Pregnant and Postpartum Women

por Robinson, William A., McMillan, Colette, Kendall, Amy, Pearlman, Nathan
Publicado 2012

Avapritinib for Cutaneous Mastocytosis

por LEE, Hannah, LI, Tian, WISELL, Joshua, SCHOWINSKY, Jeffrey, ROBINSON, William A.
Publicado 2021

Long Term Storage of Dry versus Frozen RNA for Next Generation Molecular Studies

por Seelenfreund, Eric, Robinson, William A., Amato, Carol M., Tan, Aik-Choon, Kim, Jihye, Robinson, Steven E.
Publicado 2014

IMPACT web portal: oncology database integrating molecular profiles with actionable therapeutics

por Hintzsche, Jennifer D., Yoo, Minjae, Kim, Jihye, Amato, Carol M., Robinson, William A., Tan, Aik Choon
Publicado 2018

A Review and Clinical Perspective of the Impact of Osteoporosis on the Spine

por Carlson, Bayard C., Robinson, William A., Wanderman, Nathan R., Sebastian, Arjun S., Nassr, Ahmad, Freedman, Brett A., Anderson, Paul A.
Publicado 2019

Severe paraneoplastic hypoglycemia in a patient with a gastrointestinal stromal tumor with an exon 9 mutation: a case report

por Escobar, Guillermo A, Robinson, William A, Nydam, Trevor L, Heiple, Drew C, Weiss, Glen J, Buckley, Linda, Gonzalez, Rene, McCarter, Martin D
Publicado 2007

Extracellular Vesicles Secreted from Cancer Cell Lines Stimulate Secretion of MMP-9, IL-6, TGF-β1 and EMMPRIN

por Redzic, Jasmina S., Kendrick, Agnieszka A., Bahmed, Karim, Dahl, Kristin D., Pearson, Chad G., Robinson, William A., Robinson, Steven E., Graner, Michael W., Eisenmesser, Elan Z.
Publicado 2013

Combining a BCL2 Inhibitor with the Retinoid Derivative Fenretinide Targets Melanoma Cells Including Melanoma Initiating Cells

por Mukherjee, Nabanita, Reuland, Steven N., Lu, Yan, Luo, Yuchun, Lambert, Karoline, Fujita, Mayumi, Robinson, William A, Robinson, Steven E, Norris, David A., Shellman, Yiqun G.
Publicado 2014

Analysis of Human Leukocyte Antigen DR Alleles, Immune-Related Adverse Events, and Survival Associated With Immune Checkpoint Inhibitor Use Among Patients With Advanced Malignant M...

por Akturk, Halis Kaan, Couts, Kasey L., Baschal, Erin E., Karakus, Kagan E., Van Gulick, Robert J., Turner, Jacqueline A., Pyle, Laura, Robinson, William A., Michels, Aaron W.
Publicado 2022

Transcriptome Profiling of Whole Blood Cells Identifies PLEK2 and C1QB in Human Melanoma

por Luo, Yuchun, Robinson, Steven, Fujita, Junichi, Siconolfi, Lisa, Magidson, Jay, Edwards, Carl K., Wassmann, Karl, Storm, Kathleen, Norris, David A., Bankaitis-Davis, Danute, Robinson, William A., Fujita, Mayumi
Publicado 2011

Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells

por Mukherjee, Nabanita, Lu, Yan, Almeida, Adam, Lambert, Karoline, Shiau, Chung-Wai, Su, Jung-Chen, Luo, Yuchun, Fujita, Mayumi, Robinson, William A., Robinson, Steven E., Norris, David A., Shellman, Yiqun G.
Publicado 2016

A Novel Regimen for Treating Melanoma: MCL1 Inhibitors and Azacitidine

por Dart, Chiara R., Mukherjee, Nabanita, Amato, Carol M., Goulding, Anabel, MacBeth, Morgan, Van Gulick, Robert, Couts, Kasey L., Lambert, James R., Norris, David A., Robinson, William A., Shellman, Yiqun G.
Publicado 2021

BH3 mimetics induce apoptosis independent of DRP-1 in melanoma

por Mukherjee, Nabanita, Strosnider, Andrew, Vagher, Bay, Lambert, Karoline A., Slaven, Sarah, Robinson, William A., Amato, Carol M., Couts, Kasey L., Bemis, Judson G. T., Turner, Jacqueline A., Norris, David A., Shellman, Yiqun G.
Publicado 2018

CTLA4 mRNA is downregulated by miR-155 in regulatory T cells, and reduced blood CTLA4 levels are associated with poor prognosis in metastatic melanoma patients

por Vaddi, Prasanna Kumar, Osborne, Douglas Grant, Nicklawsky, Andrew, Williams, Nazanin K., Menon, Dinoop Ravindran, Smith, Derek, Mayer, Jonathan, Reid, Anna, Domenico, Joanne, Nguyen, Giang Huong, Robinson, William A., Ziman, Melanie, Gao, Dexiang, Zhai, Zili, Fujita, Mayumi
Publicado 2023

BRAF Modulates Lipid Use and Accumulation

por Turner, Jacqueline A., Paton, Emily L., Van Gulick, Robert, Stefanoni, Davide, Cendali, Francesca, Reisz, Julie, Tobin, Richard P., McCarter, Martin, D’Alessandro, Angelo, Torres, Raul M., Robinson, William A., Couts, Kasey L., Schlaepfer, Isabel R.
Publicado 2022

Combining a GSI and BCL-2 inhibitor to overcome melanoma's resistance to current treatments

por Mukherjee, Nabanita, Almeida, Adam, Partyka, Katie A., Lu, Yan, Schwan, Josianna V., Lambert, Karoline, Rogers, Madison, Robinson, William A, Robinson, Steven E, Applegate, Allison J, Amato, Carol M, Luo, Yuchun, Fujita, Mayumi, Norris, David A., Shellman, Yiqun G.
Publicado 2016

Side Population Cells from Human Melanoma Tumors Reveal Diverse Mechanisms for Chemoresistance

por Luo, Yuchun, Ellis, Lixia Z, Dallaglio, Katiuscia, Takeda, Moe, Robinson, William A, Robinson, Steven, Liu, Weimin, Lewis, Karl D, McCarter, Martin D, Gonzalez, Rene, Norris, David A, Roop, Dennis R, Spritz, Richard A, Ahn, Natalie G, Fujita, Mayumi
Publicado 2012